A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long non-coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson's disease cell model.
Kefeng Lv, Yuhua Liu, Yanbing Zheng, Shaowen Dai, Peifeng Yin, Haifeng Miao. Biol Res 2021
1
100

Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease.
Eleanor Sinclair, Drupad K Trivedi, Depanjan Sarkar, Caitlin Walton-Doyle, Joy Milne, Tilo Kunath, Anouk M Rijs, Rob M A de Bie, Royston Goodacre, Monty Silverdale,[...]. Nat Commun 2021
8
50

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Penelope G Foulds, J Douglas Mitchell, Angela Parker, Roisin Turner, Gerwyn Green, Peter Diggle, Masato Hasegawa, Mark Taylor, David Mann, David Allsop. FASEB J 2011
117
50

Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.
Stylianos Ravanidis, Anastasia Bougea, Dimitra Karampatsi, Nikolaos Papagiannakis, Matina Maniati, Leonidas Stefanis, Epaminondas Doxakis. Mov Disord 2021
6
50

Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 Patients.
Luis E Almaguer-Mederos, Ilbedis Pérez-Ávila, Raúl Aguilera-Rodríguez, Maria Velázquez-Garcés, Dennis Almaguer-Gotay, Ricardo Hechavarría-Pupo, Annelié Rodríguez-Estupiñán, Georg Auburger. Mov Disord 2021
2
50

The path linking disease severity and cognitive function with quality of life in Parkinson's disease: the mediating effect of activities of daily living and depression.
Yao He, Yuling Tian, Hongjuan Han, Jing Cui, Xiaoyan Ge, Yao Qin, Yanhong Luo, Wenlin Bai, Hongmei Yu. Health Qual Life Outcomes 2021
1
100

Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.
Lei Chen, Junxiu Yang, Jinhui Lü, Shanshan Cao, Qian Zhao, Zuoren Yu. Brain Behav 2018
36
50

A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.
Paola Piscopo, Maria Bellenghi, Valeria Manzini, Alessio Crestini, Giada Pontecorvi, Massimo Corbo, Elena Ortona, Alessandra Carè, Annamaria Confaloni. Int J Mol Sci 2021
4
50

Genetic Analysis of ZNF Protein Family Members for Early-Onset Parkinson's Disease in Chinese Population.
Chun Yu Li, Ru Wei Ou, Yong Ping Chen, Xiao Jing Gu, Qian Qian Wei, Bei Cao, Ling Yu Zhang, Yan Bing Hou, Kun Cheng Liu, Xue Ping Chen,[...]. Mol Neurobiol 2021
1
100

Association of the Plasma Long Non-coding RNA MEG3 With Parkinson's Disease.
Yi Quan, Jia Wang, Shuo Wang, Jizong Zhao. Front Neurol 2020
3
50


Towards optimising experimental quantification of persistent pain in Parkinson's disease using psychophysical testing.
Kirsty Bannister, Rory V Smith, Patrick Wilkins, Tatum M Cummins. NPJ Parkinsons Dis 2021
3
50

Sleep disturbance in movement disorders: insights, treatments and challenges.
Grace A Bailey, Emily K Hubbard, Alfonso Fasano, Marina Aj Tijssen, Timothy Lynch, Kirstie N Anderson, Kathryn J Peall. J Neurol Neurosurg Psychiatry 2021
1
100

Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.
Biswadeep Das, Sriya Priyadarshini Dash, Swabhiman Mohanty, Paritosh Patel. Adv Exp Med Biol 2021
2
50

Bone-Derived Factors as Potential Biomarkers for Parkinson's Disease.
Yuwan Lin, Miaomiao Zhou, Wei Dai, Wenyuan Guo, Jiewen Qiu, Zhiling Zhang, Mingshu Mo, Liuyan Ding, Panghai Ye, Yijuan Wu,[...]. Front Aging Neurosci 2021
1
100

Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Jie Lin, Dongping Cai, Wei Li, Ting Yu, Hui Mao, Shan Jiang, Bin Xiao. Clin Biochem 2019
34
50

Peripheral markers in neurodegenerative patients and their first-degree relatives.
Diana Olga Cristalli, Nathalie Arnal, Fernando Ariel Marra, María J T de Alaniz, Carlos Alberto Marra. J Neurol Sci 2012
60
50

Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic Accuracy.
Antonia Franz, Bernhard Ralla, Sabine Weickmann, Monika Jung, Hannah Rochow, Carsten Stephan, Andreas Erbersdobler, Ergin Kilic, Annika Fendler, Klaus Jung. Cancers (Basel) 2019
18
50

A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks.
Cai Huaying, Jin Xing, Jin Luya, Ni Linhui, Sun Di, Ding Xianjun. Front Aging Neurosci 2021
3
50

Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease.
Qiang Li, Zihao Wang, Hao Xing, Yu Wang, Yi Guo. Mol Ther Nucleic Acids 2021
6
50

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease.
Yimin Yang, Yanhua Li, Hongmei Yang, Jianxing Guo, Nan Li. Front Mol Neurosci 2021
2
50

Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection.
Yao Wei, Ming Lu, Meng Mei, Haoran Wang, Zhitao Han, Miaomiao Chen, Hang Yao, Nanshan Song, Xiao Ding, Jianhua Ding,[...]. Nat Commun 2020
19
50

Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
Xiaochen Bai, Yilin Tang, Mei Yu, Lei Wu, Fengtao Liu, Jianliang Ni, Zishan Wang, Jinghui Wang, Jian Fei, Wei Wang,[...]. Sci Rep 2017
41
50

Neuropsychological Test Performance in Parkinsonism Without Dopaminergic Deficiency on [123I]-FP-CIT SPECT Imaging.
Kathryn A Wyman-Chick, Phillip K Martin, Michal Minár, Manuel Menéndez-González, Lauren O Erickson, Tania Álvarez-Avellón, Ryan W Schroeder. J Int Neuropsychol Soc 2018
4
50


DYT-1 gene dystonic tremor presenting as a "scan without evidence of dopaminergic deficit".
María T Cáceres-Redondo, Fátima Carrillo, Francisco J Palomar, Pablo Mir. Mov Disord 2012
6
50

Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Jerrold L Vitek, Roy A E Bakay, Alan Freeman, Marian Evatt, Joanne Green, William McDonald, Michael Haber, Huiman Barnhart, Natalie Wahlay, Shirley Triche,[...]. Ann Neurol 2003
131
50

24-Hour Ambulatory Blood Pressure Monitoring in SWEDDs Patients With Parkinsonism.
Seok-Jae Kang, Jin Young Ahn, Joong-Seok Kim, Jin Whan Cho, Ji Young Kim, Yun Young Choi, Hee-Tae Kim. Can J Neurol Sci 2016
8
50

Feasibility of the Medial Temporal lobe Atrophy index (MTAi) and derived methods for measuring atrophy of the medial temporal lobe.
Francisco Conejo Bayón, Jesús Maese, Aníbal Fernandez Oliveira, Tamara Mesas, Estibaliz Herrera de la Llave, Tania Alvarez Avellón, Manuel Menéndez-González. Front Aging Neurosci 2014
8
50

Accuracy of Visual Assessment of Dopamine Transporter Imaging in Early Parkinsonism.
Susanna Jakobson Mo, Jan Linder, Lars Forsgren, Katrine Riklund. Mov Disord Clin Pract 2014
5
50

Longitudinal follow-up of SWEDD subjects in the PRECEPT Study.
Kenneth Marek, John Seibyl, Shirley Eberly, David Oakes, Ira Shoulson, Anthony E Lang, Chris Hyson, Danna Jennings. Neurology 2014
93
50


Scan without evidence of dopaminergic deficit: A 10-year retrospective study.
Nicolas Nicastro, Valentina Garibotto, Simon Badoud, Pierre R Burkhard. Parkinsonism Relat Disord 2016
23
50

The semicolon sign: dopamine transporter imaging artifact from head tilt.
Matthew F Covington, Natalie A McMillan, Ryan J Avery, Phillip H Kuo. J Nucl Med Technol 2013
9
50

CSF and blood biomarkers for Parkinson's disease.
Lucilla Parnetti, Lorenzo Gaetani, Paolo Eusebi, Silvia Paciotti, Oskar Hansson, Omar El-Agnaf, Brit Mollenhauer, Kaj Blennow, Paolo Calabresi. Lancet Neurol 2019
116
50

Hyposmia in SWEDD.
L Silveira-Moriyama, J Birchall, P Bain, A J Lees, N P S Bajaj. Mov Disord 2015
3
50

Paraneoplastic stiff person syndrome associated with colon cancer misdiagnosed as idiopathic Parkinson's disease worsened after capecitabine therapy.
Sasa Badzek, Vladimir Miletic, Juraj Prejac, Irma Gorsic, Hilda Golem, Ervina Bilic, Domina Kekez, Niksa Librenjak, Stjepko Plestina. World J Surg Oncol 2013
11
50

Local White Matter Fiber Clustering Differentiates Parkinson's Disease Diagnoses.
Yuanjing Feng, Wenxuan Yan, Jingqiang Wang, Jiahao Song, Qingrun Zeng, Changchen Zhao. Neuroscience 2020
1
100

[Negative predictive value of (123)I Ioflupane SPECT in movement disorders].
J Serrano Vicente, L García Bernardo, C Durán Barquero, A Constantino Silva, J R Infante de la Torre, M L Domínguez Grande, J I Rayo Madrid, R Sánchez Sánchez, C Durán Herrera. Rev Esp Med Nucl 2009
6
50

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.
Danna L Jennings, John P Seibyl, David Oakes, Shirley Eberly, John Murphy, Ken Marek. Arch Neurol 2004
122
50

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
Hani T S Benamer, Wolfgang H Oertel, Jim Patterson, Donald M Hadley, Oliver Pogarell, H Höffken, A Gerstner, Donald G Grosset. Mov Disord 2003
104
50

Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study.
Manuel Menéndez-González, Francisco Tavares, Nahla Zeidan, José M Salas-Pacheco, Oscar Arias-Carrión. Front Aging Neurosci 2014
30
50

Re-emergent tremor in a dystonic SWEDD case.
Karlijn F de Laat, Bart P van de Warrenburg. Mov Disord 2012
8
50

Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
Andrea Pilotto, Enrico Premi, Silvia Paola Caminiti, Luca Presotto, Rosanna Turrone, Antonella Alberici, Barbara Paghera, Barbara Borroni, Alessandro Padovani, Daniela Perani. Neurology 2018
30
50

Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.
Vicky L Marshall, Jim Patterson, Donald M Hadley, Katherine A Grosset, Donald G Grosset. Nucl Med Commun 2006
79
50

Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration.
Sean S O'Sullivan, David J Burn, Janice L Holton, Andrew J Lees. Mov Disord 2008
30
50

Parkinsonian signs and substantia nigra neuron density in decendents elders without PD.
G Webster Ross, Helen Petrovitch, Robert D Abbott, James Nelson, William Markesbery, Daron Davis, John Hardman, Lenore Launer, Kamal Masaki, Caroline M Tanner,[...]. Ann Neurol 2004
151
50


Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration.
Valtteri Kaasinen, Maria Gardberg, Matias Röyttä, Marko Seppänen, Markku Päivärinta. J Neurol 2013
16
50

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.